Modern Pediatrics. Ukraine. (2024). 1(137): 30-36. doi: 10.15574/SP.2024.137.30
Koloskova O. K.¹, Ivanova L. A.¹, Tarnavska S. I.¹, Marusyk U. I.¹, Huk L. I.^2
1Bukovinian State Medical University, Chernivtsi, Ukraine
²RCnPE «Chernivtsi Regional Children’s Clinical Hospital», Ukraine

For citation: Koloskova OK, Ivanova LA, Tarnavska SI, Marusyk UI, Huk LI. (2024). Experience of using the probiotic Bacillus clausii UBBC-07 in children of early age with acute watery diarrhea in the conditions of a hospital department. Modern Pediatrics. Ukraine. 1(137): 30-36. doi: 10.15574/SP.2024.137.30.

Article received: Dec 11, 2023. Accepted for publication: Feb 12, 2024.

Acute watery diarrhea in children remains an urgent problem in pediatrics due to its high prevalence and high mortality rates at an early age. Modern treatment protocols provide for a comprehensive approach to the treatment of patients. However, the main method of treatment of diarrhea – oral rehydration, does not allow for the stoppage of the progression of gastroenteritis, of the elimination of the imbalance of microflora and intestinal dysfunction. Such tasks can be solved thanks to the use of probiotics, which are recommended as a component of auxiliary therapy for children with acute infectious diarrhea.

Purpose – to conduct a comprehensive clinical and epidemiological analysis of the results of the use of the spore-forming probiotic Bacillus clausii (B. clausii) strain UBBC-07 (Lactiale Germina) in the complex treatment of hospitalized young children with acute infectious watery diarrhea syndrome.

Materials and methods. 85 children with acute infectious non-inflammatory diarrhea were comprehensively examined. 2 clinical groups were formed. The Group I – 50 hospitalized children (average age 3.1±0.4 years, the proportion of boys – 64.0%), who received 1 bottle of Lactiale Germina 1 time/day in complex treatment (5 ml=2×10⁹ CFU B. clausii endospores). The Group II included 35 patients (average age 2.4±0.4 years (p>0.05), the share of boys – 54.3% (p>0.05)); who received standard treatment according to existing standards. According to the main clinical characteristics, the comparison groups can be considered comparable.

Results. The analysis of the conducted studies established that the use of Lactial Germin increased the chances of a three-fold reduction in the frequency of bowel movements on the 4^th day (absolute risk increase (ARI) – 27.0%, relative risk increase (RRI) – 34.6 (95% CI: 25.4-44.8) with the minimum number of patients who need to be treated to obtain a positive result (MNP) – 2.9 (95% CI: 0.5-8.6), led to the absence of the symptom of vomiting already for the 3^rd day of inpatient treatment (ARI – 9.0%, RRI – 37.5 (95% CI: 28.0-47.7) with MNP – 2.7 (95% CI: 0.4-8.1), increased the chances of a lower need for long-term (≥3 days) parenteral rehydration (ARI – 12.9%, RRI – 13.7% (95% CI: 7.6-22.1) with MNP – 7.3 (95% CI: 2.9-14.3) and reduced the risk of needing to use antidiarrheal agents (relative risk – 3.2 (95% CI: 2.6-3.9) with an odds ratio – 7.1 (95% CI: 3,4-14,7)).

Conclusions. Food supplement Lactiale Germina (probiotic strain B. clausii strain UBBC-07) in the complex treatment of children with acute watery diarrhea is effective and safe with good tolerability and rapid rates of clinical recovery.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

Keywords: Lactiale Germina, B. сlausii, watery diarrhea, children.

REFERENCES

1. Allen SJ, Martinez EG, Gregorio GV, Dans LF. (2010). Probiotics for treating acute infectious diarrhoea. Cochrane Data base Syst Rev. 11: CD003048. Update in: CochraneDatabaseSystRev. 2020;12:CD003048. https://doi.org/10.1002/14651858.CD003048.pub3; PMid:21069673 PMCid:PMC6532699

2. Alrafiaah AS, Albraikan A, AlJaafari A, AlAbbad A, Alfehaid H, Alqueflie S, Omair A. (2022). Assessment of Maternal Knowledge and Practices Regarding Acute Diarrheal Illnesses in Children in Saudi Arabia: A Tertiary Care Center Survey. Cureus. 14 (12): e33116. https://doi.org/10.7759/cureus.33116; PMid:36726908 PMCid:PMC9886366

3. Bolla VL, Jyothi M, Mettu SR, Manoj Kumar MG, Rao KN, Reddy MS, Koppolu P. (2023). Effectiveness of three mouth rinsing agents against mutans Streptococcus and Lactobacillus species – A comparativestudy. Ann Afr Med. 22 (3): 365-372. https://doi.org/10.4103/aam.aam_95_22; PMid:37417027 PMCid:PMC10445715

4. Burke RM, Rebolledo PA, Embrey SR, Wagner LD, Cowden CL, Kelly FM, Smith ER, Iñiguez V, Leon JS. (2013). The burden of pediatric diarrhea: A cross-sectional study of incurred costs and perceptions of cost among Bolivian families. BMC Public Health. 13: 708. https://doi.org/10.1186/1471-2458-13-708; PMid:23915207 PMCid:PMC3737018

5. Chen J, Wan CM, Gong ST, Fang F, Sun M, Qian Y, Huang Y, Wang BX, Xu CD, Ye LY, Dong M, Jin Y, Huang ZH, Wu QB, Zhu CM, Fang YH, Zhu QR, Dong YS. (2018). Chinese clinical practice guidelines for acute infectious diarrhea in children. World J Pediatr. 14 (5): 429-436. https://doi.org/10.1007/s12519-018-0190-2; PMid:30269306

6. Collinson S, Deans A, Padua-Zamora A, Gregorio GV, Li C, Dans LF, Allen SJ. (2020). Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 12 (12): CD003048. https://doi.org/10.1002/14651858.CD003048.pub4; PMid:33295643 PMCid:PMC8166250

7. Gianluca Ianiro, Gianenrico Rizzatti, Manuel Plomer, Loris Lopetuso, Franco Scaldaferri, Francesco Franceschi, Giovanni Cammarota, Antonio Gasbarrini. (2018). Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 10 (8): 1074. https://doi.org/10.3390/nu10081074; PMid:30103531 PMCid:PMC6116021

8. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. (2015). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 12: CD004827. Updatein: CochraneDatabaseSystRev. 2019;4:CD004827. https://doi.org/10.1002/14651858.CD004827.pub4; PMid:26695080

9. Guarino A, Ashkenazi S, Gendrel D, LoVecchio A, Shamir R, Szajewska H. (2014). European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J PediatrGastroenterolNutr. 59 (1): 132-52. https://doi.org/10.1097/MPG.0000000000000375; PMid:24739189

10. Khaliq A, Holmes-Stahlman R, Ali D, Karatela S, Lassi ZS. (2023). Assessment of Determinants of Paediatric Diarrhoea Case Management Adherence in Pakistan. Life (Basel). 13 (3): 677. https://doi.org/10.3390/life13030677; PMid:36983833 PMCid:PMC10053143

11. Kharwar A, Bazaz MR, Dandekar MP. (2022). Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus сlausii spores. BMC Microbiol. 22 (1): 217. https://doi.org/10.1186/s12866-022-02631-w; PMid:36114449 PMCid:PMC9482283

12. Lahiri KR, Singh R, Apte M, Patil M, Taksande A, Varona R, Chatterjee G, Verma M, Brette S, Perez MI. (2022). Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India. Trop Dis Travel Med Vaccines. 8 (1): 9. https://doi.org/10.1186/s40794-022-00166-6; PMid:35397572 PMCid:PMC8994895

13. Li Z, Zhu G, Li C, Lai H, Liu X, Zhang L. (2021). Which Probiotic Is the Most Effective for Treating Acute Diarrhea in Children? A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Nutrients. 13 (12): 4319. https://doi.org/10.3390/nu13124319; PMid:34959871 PMCid:PMC8706888

14. Meier JL. (2021). Viral Acute Gastroenteritis in Special Populations. Gastroenterol Clin North Am. 50 (2): 305-322. https://doi.org/10.1016/j.gtc.2021.02.003; PMid:34024443

15. Mendelsohn AS, Asirvatham JR, Mkaya Mwamburi D, Sowmynarayanan TV, Malik V, Muliyil J, Kang G. (2008). Estimate softheeconomic burden of rotavirus-associated and all-cause diarrhoeain Vellore, India. Trop. Med. Int. Health. 13: 934-942. https://doi.org/10.1111/j.1365-3156.2008.02094.x; PMid:18466182 PMCid:PMC2473264

16. Ratna Sudha M, Jayanthi N, Pandey DC, Verma AK. (2019). Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study Benef Microbes. 10 (2): 149-154. https://doi.org/10.3920/BM2018.0094; PMid:30638396

17. UNICEF. (2021). Diarrhoearemains a leadingkillerofyoungchildren, despitetheavailabilityof a simpletreatment solution. URL: https://data.unicef.org/topic/child-health/diarrhoeal-disease/. Accessed on 03.08.2021.

18. Zhonghua Yu Fang Yi Xue Za Zhi. (2020). Analysis of pathogenic composition and clinical characteristics of viral acute gastroenteritis in children under five years old in Beijing. 54 (10): 1104-1110. doi: 10.3760/cma.j.cn112150-20191129-00892.